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Abstract Galectin-3 is a galactose-specific lectin which has been 
shown to be involved in several biological functions such as cell 
growth regulation, cell aggregation and cell differentiation. The 
partial cloning of the human genomic sequences reveals the pres- 
ence of a 651 bp intron, 18 bp downstream of the translation 
initiation site. This intron contains several regulatory elements 
found in many eukaryotic genes. This sequence, when inserted 
upstream of a promoter-free luciferase gene, induces the expres- 
sion of luciferase, demonstrating the promoter activity of the 
intron upon transfection in human or murine cells. This promoter 
activity is down-modulated by wild-type ~53 but not by a mutated 
form of ~53. 
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1. Introduction 
Galectin-3 [l], a soluble galactose binding lectin, has been 
identified independently by different laboratories. On the basis 
of cDNA sequencing, all galectins-3 are closely homologous, 
namely CBP35 from 3T3 fibroblasts [2], L-31 and L-34 from 
human and murine tumour cells [3,4], Mac-2 from human and 
rat macrophages [5,6], Ig-E binding protein or E BP from baso- 
philic leukaemia cells [7,8], and L-29 in human and rat lung 
[9,10]. The protein can be found intracellularly in the cytosol 
and in the nucleus and extracellularly in the medium and at the 
cell surface [3,1 l-141, suggesting its involvement in various bio- 
logical processes. The lectin expression changes during devel- 
opment [15], is modulated by serum stimulation and is depend- 
ent on the cell growth status [16,17]. The lectin expression is 
also increased upon oncogene or viral transformation 
[4,11,18,19] and is high in a wide range of human and murine 
tumour cells [11,20]. The murine L-34 could play a role in 
metastasis as an active component in the progression of tumour 
to metastatic cells [4,21]. In addition, this lectin, as an IgE 
binding protein, may also be involved in allergic disorders 
[8,22]. In macrophages, the lectin is elicited by inflammatory 
stimuli and is regarded as a differentiation marker [5]. 
So far, little is known about the regulation of lectin gene 
expression. We undertook the determination of the genomic 
sequences corresponding to the 5’ moiety of the human ga- 
lectin-3 gene using the ligation mediated-polymerase chain re- 
action (LM-PCR) [23]. We describe the isolation and character- 
ization of an intron located within the coding sequence 18 bp 
downstream of the translation initiation ATG codon. Its 
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sequence reveals several regulatory elements known as consen- 
sus sequences specific for various transcription activators of 
eukaryotic genes. Furthermore this intron, when inserted into 
a plasmid containing a promoter-free reporter gene, elicits a 
strong promoter activity which is, in addition, down-modulated 
by wild-type ~53 but not by mutated ~53. 
2. Materials and methods 
2.1. Cloning of genomic sequences by ligation mediated PCR 
10 ,ug of human placental genomic DNA were digested with the 
restriction enzyme Hind111 (New England Bioloabs, MA) and ligated 
to 6 pg of pUCl8 plasmid DNA previously cut with Hind111 and 
EcoRI. 1 pug of DNA of the ligation ieaction was used as the template 
for PCR which was carried out in a DNA Thermocvcler (Perkin-Elmer- 
Cetus, Norwalk, CT) in a reaction mixture containing ‘1.25 U of Taq 
DNA polymerase (Promega Corp., Madison, WI) and 1 PM of each 
PCR primer in 50 ~1 lx Tag polymerase buffer. The PCR primer 
MN-l 1, 5’-AGTGCCACCTGACGTCTAAG-3’, is complementary to 
a sequence on pUCl8 (nt 2608-2628); the PCR primer MN-39, 5’- 
GTAGCCCCTGCCCAGCAGGCTGGTT-3’, is located 82-108 bp 
downstream of the ATG translation initiation codon of the human 
galectin-3 cDNA [4,6,8] (Fig. 1). Thirty amplification cycles were per- 
formed (1 min denaturation at 94”C, 2 min annealing at 55°C and 3 min 
extension at 72°C). 2 ~1 of the reaction were used as the template for 
a second round of PCR using two nested primers M13F, 5’- 
GTAAAACGACGGCCAGT-3’, located on pUC18 (nt 379-395) and 
GAL67, 5’-ATCCTTGAGGGTTTGGGTTT-3’, located 45-64 bp 
downstream of the ATG translation initiation codon on the galectin-3 
cDNA [4,6,8]. 1 ~1 of this second PCR reaction was used for ligation 
with a linearized pCRlOO0 plasmid vector and transformation of Esch- 
erichia coli as recommended by the manufacturer (TA cloning system; 
Invitrogen Corp., San Diego, CA). Colonies were probed with GAL25, 
5’-ATGGCAGACAATTTTTCGCTCC-3’, an oligonucleotide inter- 
nal to GAL67 and located from nt I to 22 on the galectin cDNA. 
Positive plasmids were sequenced on both strands using Sequenase 
(United States Biochemical, Cleveland, OH). 
2.2. Construction of reporter plasmids and transfections 
The PCR fragment was excised from the pCRlOO0 plasmid after 
cleavage with Not1 and Hind111 and introduced at the same sites into 
pGEM1 lZ(f-) (Promega Corp., Madison, WI). The luciferase reporter 
gene was isolated from pOLUC [24] by BamHI and Sac1 and intro- 
duced downstream of the intron into the plasmid at the same sites to 
produce the expression vector pGEM99-LUC. Insertion of the PCR 
fragment, in reverse orientation with respect to the luciferase gene, 
produced the plasmid pGEM99R-LUC. Deletion of the PCR fragment 
in pGEM99-LUC produced the promoter-free luciferase gene vector 
pGEM-LUC used as a negative control. A positive control was ob- 
tained by transfection with pSVZLUC, a plasmid in which the luciferase 
gene is driven by the SV40 early region promoter [24]. These vectors 
were transfected, according to Midoux et al. [25], into human osteosar- 
coma HOS (American Type and Culture Collection CRL 1543. Rock- 
ville, MD) and murine -macrophages 5774 cells clone E [26j which 
express the mRNA specific for the lectin. Briefly, lo6 cells were incu- 
bated for 4 h in a medium containing 100 PM chloroquine and 5 pg of 
plasmid DNA complexed with 12.5 pg glycosylated poly-L-lysine. 48 h 
later, luciferase activity was assayed, using an automated luminometer 
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(Berthold Lumat LB 9501; Colombes, France). Co-transfection exper- 
iments were performed by using 5 pg of pGEM-99LUC and 0.5 pg of 
pBR322 or of p53SN3 or of p53SCX3; these two last vectors encode 
for wild-type or mutated ~53, respectively [27]. 
2.3. cDNA synthesis and umplification with PCR (RT-PCR) 
2 ,ag of total cell RNA, extracted from HOS cells by the guanidium- 
phenol-chloroform method [28], were reverse transcribed in a reaction 
mixture containing 30 U AMV reverse transcriptase (Promega Corp., 
Madison, WI), and 200 PM of the primer GAL764, Y-TCTGCCCC- 
TTTCAGATTATATC-3’, located from nt 747 to 768 at the 3’end of 
the galectin-3 cDNA 141 in 20 ~1 reaction buffer for 2 h at 42°C. 
One-tenth of the react& was used as the template for 30 PCR cycles 
initiated with a 3’ mimer MN-38. S-TCTGTTTGCATTGGGTTC- 
ACC-3’, located up&earn of GALj64 from nt 411 to 432 on the cDNA 
and GALi 16, 5’-TTCTGATGTTTGTGATTGTTTTTC-3’, located 
from nt 3 17 to 340 in the cloned PCR fragment (Fig. 2). A second round 
of PCR was performed using one-fiftieth of the first PCR product. 
3. Results 
3.1. Cloning ofgenomic DNA by ligation mediated-PCR 
The genome walking scheme is shown in Fig. 1. Human 
genomic DNA was digested with different enzymes and ligated 
onto the linearized vector pUCl8. The resulting ligation prod- 
ucts were amplified by using primers MN- 11 and MN-39 which 
lie on the cloning vector and on the galectin-3 gene, respec- 
tively. Upon gel electrophoresis, the amplified products ap- 
peared as a smear with few discrete bands barely visible (not 
shown). In order to enhance the specific amplification, a second 
round of PCR was performed with two nested primers, M13F 
and GAL67, which are located on the cloning vector and on 
the 5’ part of the coding region of the cDNA, respectively. A 
unique band of about 800 bp was visualized by gel electropho- 
resis (not shown). This PCR fragment was inserted into the 
pCRlOO0 vector. Positive clones were screened with GAL25, 
an internal primer, and sequenced. 
3.2. Characterization of the human genomic sequence around the 
translation initiation site 
The expected PCR fragment should have at one end the 
M 13F primer from pUCl8 DNA followed by the Hind111 clon- 
ing site (Fig. 1) and at the other end the GAL67 primer. The 
sequence, reported in Fig. 2, has indeed such a structure. The 
exact size is 778 bp in good agreement with the gel electropho- 
resis data. Upstream of the PCR primer GAL67 the first 26 bp 
are identical to those of the published sequence of the cDNA 
(GenBank accession numbers JO2921, M35364, M36682, 
M64303) but further on the sequence of the PCR product 
diverges from that of the cDNA; the 26 bp sequence contains 
the four last 3’ bases of GAL25, the oligonucleotide used as a 
probe. The remaining 18 bp of GAL25, which contains the 
ATG translation initiation codon, were found 63 bp down- 
stream of the 5’ end in the PCR fragment, indicating that an 
intervening sequence of 651 bp is located within the sequence 
of GAL25. Consensus sequences for 5’ and 3’ splicing sites of 
the intervening sequence are present, confirming this assump- 
tion. Four bp upstream of the ATG translation initiation codon 
the sequence of the PCR fragment diverges again from the 
cDNA indicating the presence of another intervening sequence. 
Thus, the ATG translation initiation codon is contained within 
a short 22 bp exon. This structure in the 5’ end of the coding 
sequence appears to be identical to that of the murine galectin-3 
pUC18 Genomic DNA 
\/ 
MN-11 H ATG MN-39 
M13F Gal67 
I) H ATG + 
I 
H ATG 
- 
Gal25 
Fig. 1. Experimental design for cloning of genomic sequences by LM- 
PCR. Human genomic DNA (black boxes) digested with Hind111 (H) 
was ligated to pUCl8 (open boxes) previously double digested with 
Hind111 and EcoRI (E) in order to avoid self ligation. PCR was initiated 
with two primers located on pUCl8 (MN-l 1) and downstream of the 
ATG translation initiation codon site of the galectin-3 gene (MN-39). 
A second round of PCR was initiated with nested primers (Ml3F and 
GAL67) in order to specifically amplify the relevant sequences. The 
PCR product was inserted into pCRlOO0 and clones were screened with 
GAL25, an internal primer located at the 5’ end of the coding sequence 
of the gene of galectin-3 cDNA. 
gene [29]. Consequently the incomplete intervening sequence at 
the 5’ end of the PCR fragment represents very likely the first 
intron of the human galectin-3 gene, the 22 bp exon is the 
second exon and the 651 bp intron is the second intron. 
Consensus sequences specific for transcription factors AP-1, 
AP-2, GC box, NFfcB, CTF, ~53 and CCAAT which are pres- 
ent in the 6.51 bp intron, are indicated in Fig. 2. 
3.3. Promoter activity of the cloned intron from the galectin-3 
gene 
In order to assess the putative promoter activity of the 651 
bp isolated intron, the PCR fragment was subcloned upstream 
of a promoter-free luciferase gene to produce the pGEM99- 
LUC plasmid, which was then transfected into human osteosar- 
coma HOS cells and murine macrophage 5774 clone E cells. 
The luciferase activity of these two cell types upon transfection 
with the pGEM99-LUC plasmid was quite high (Fig. 3), indi- 
cating a strong promoter activity of the sequence isolated from 
the galectin-3 gene. The activity of luciferase is lower in 5774 
clone E cells than in HOS cells; this reflects a difference in the 
transfection efficiency of these two cell types (unpublished re- 
sults). The luciferase activity in HOS cells was very high, 
around 700,000 RLU with either promoters: the SV40 early 
region or the second galectin-3 gene intron. In the monocytic 
line J774 clone E, the second galectin-3 intron used as a pro- 
moter led to a luciferase activity slightly higher (about twice) 
than when the luciferase gene was under the control of the SV40 
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Fig. 2. Nucleotide sequence and regulatory elements from the PCR fragment containing a complete intron of the galectin-3 gene. The nucleotides 
in lower case letters represent the sequence from the pUC18 plasmid from primer Ml 3F up to the Hind111 cloning site. The boldnucleotides represent 
the sequence of the published cDNA. The sequence located downstream of the Hind111 site and upstream of the GAL25 mimer is the 3’ end of an 
incomplete intron and the sequence downstream the GAL25 represents a complete 651 bp intron.‘The ATG translation initiation codon is located 
at the 5’ end of the GAL25 primer. Italics represent consensus sequences for 5’ and 3’ splicing sites of intron sequences (named 5’s~ and 3’s~). Putative 
transcription elements are underlined (APl, NFKB, CTF, AP-2, CCAAT and GC box). The consensus binding site for ~53, consisiting of two 10 
bp motifs [27], is stippled. Doubly underlined nucleotides mark the sequences of the oligonucleotides GAL25 used as a probe after cloning the PCR 
fragment, GAL67 used as PCR primer and GALi for detection of transcripts by RT-PCR. Nucleotides are numbered relative to the first base 
of the 651 bp intron. This sequence has been submitted to the GenBanklEMBL Data Bank with accession number U10300. 
early region. When the second galectin-3 intron was inserted in 
reverse orientation (pGEM99R-LUC), the luciferase activity 
was very low, about 15 times lower than that obtained with 
pGEM99-LUC (Fig. 3A). 
Because the second galectin-3 intron contains a putative ~53 
binding site [30], we were interested to know whether the inter- 
nal promoter activity could be sensitive to p53 status. HOS cells 
were co-transfected, in eight independent experiments, with 
pGEM99-LUC as above and with pc53SN3, a plasmid encod- 
ing wild-type ~53 [27]. Under such conditions, the luciferase 
activity was 8-10 times lower than that obtained after co-trans- 
fection with pBR322 in place of pc53SN3. This down-modula- 
tion was not observed when pc53SCX3, a vector encoding a 
mutated form of ~53, was used. Addition of a P-galactosidase 
encoding vector revealed no changes in the efficiency of trans- 
fection when wild-type or mutated ~53 plasmids are used, indi- 
cating that the down-modulation effect is not the result of 
differential DNA incorporation (data not shown). 
3.4. Detection of transcripts containing sequences from the 
isolated intron of galectin-3 gene in HOS cells 
Reverse transcription was performed on mRNA from HOS 
cells initiated with the primer GAL764 located at the 3’ end of 
the coding strand of the cDNA (Fig. 4). PCR was subsequently 
performed using the 3’ primer MN-38 located upstream of 
GAL764 on the cDNA and the 5’ primer GALi 16 located on 
nucleotides 316-339, in the cloned PCR fragment (Figs. 2 and 
4). A 740 bp fragment of the excpected size was detected follow- 
ing the two rounds of 30 PCR cycles. Its specificity was further 
checked by DNA sequencing (data not shown). This amplified 
fragment does not arise from contaminating genomic DNA 
because no amplification could be evidenced from PCR per- 
formed on non-reverse transcribed RNA or from amplification 
of the pre-mRNA because three additional intervening se- 
quences are located between the second intron and the GAL764 
primer on the genomic sequence (data not shown). Moreover, 
primer extension analysis performed using a primer located in 
the second intron indicates the presence of several transcription 
initiation sites within this intron (data not shown). 
The galectin-3 mRNA transcribed from the distal promoter 
were detected in a single round of 30 PCR cycles using MN-38 
and a 5’ primer, GAL04, located within the 5’ untranslated part 
of the cDNA upstream of the isolated intron (Fig. 4). These 
results indicate that in HOS cells both mRNA species are pro- 
duced. However, the relative amount of transcripts containing 
the intron sequences, detected only after two rounds of PCR, 
is scarcer than the mRNA transcribed from the distal pro- 
moter. This was confirmed by Northern analysis which shows 
a faint signal after hybridization with a probe specific for the 
intron sequence and long exposure time of the autoradiogram 
while the normal mRNA are easily detectable after hybridiza- 
tion with a cDNA probe (data not shown). 
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Fig. 3. Promoter activity of the cloned intron from the galectin-3 gene 
in the absence and in the presence of wild-type or mutated ~53. (A,B) 
Transient transfections were conducted on lo6 HOS cells (panel A) or 
5774 clone E cells (panel B) with a complex of 5 pg of plasmid DNA 
and 12.5 pg of lactosylated poly-L-lysine. Negative controls included 
mock-transfected (lanes C) and promoter-free plasmid pGEM-LUC 
transfected cells (lanes 1) while a positive control was obtained with 
pSV2-LUC transfected cells (lanes 2). Cells were transfected with the 
plasmid pGEM99-LUC which contains the intron sequence inserted 
upstream of the firefly luciferase gene reporter in direct orientation 
(lanes 3) or with pGEM99R-LUC in which the intron is in reverse 
orientation (lane 4). Luciferase activity is expressed in RLU (relative 
light units) per lo6 cells and as a percentage of that obtained with 
pSV2-LUC transfected cells. Hatched and black columns represent 
independent experiments, (C) lo6 HOS cells were co-transfected with 
5 pg of pGEM99-Luc and 0.5 pg of pBR322 or with 0.5pg of a plasmid 
encoding wild-type p53 (lane +p53) or mutated p53 (lane +p53M). 
Luciferase activity is expressed as a percentage of that obtained from 
control cells which were co-transfected with pGEM99-LUC and 
pBR322. These values are the results of eight independent experiments. 
4. Discussion 
In an attempt to understand the regulation of the expression 
of the human galectin-3 gene, we undertook to isolate the 5’ 
flanking sequence of the gene by genome walking using the 
LM-PCR technique. Because the 5’ untranslated region of the 
mRNA is not well defined due to variability of these sequences 
[5,29], we decided to initiate the genome walking a few base 
pairs downstream of the ATG codon. Upon sequencing, the 
amplified PCR product revealed the presence of a 65 1 bp intron 
located 18 nucleotides downstream of the ATG translation 
initiation codon, contained within a short exon of 22 bp. By 
homology with the mouse galectin-3 gene [29], this intron ap- 
pears to be the second intron of the gene. 
The sequence analysis of the PCR fragment revealed typical 
regulatory elements found in numerous eukaryotic genes tran- 
scribed by polymerase II [31]. This intron inserted upstream of 
a promoter-free luciferase gene acts as a strong promoter, lead- 
ing to a high level of luciferase activity in human cells trans- 
fected with such a construct. The promoter activity of the 
second galectin-3 intron is shown to be as active as much as or 
even more so than the SV40 early region. Additional data 
indicate that this internal promoter activity is not specific for 
the human galectin-3 gene and that the rabbit gene also con- 
tains a strong internal promoter in the corresponding intron 
(data not shown). These results raise the question of the use of 
this internal promoter in the cells. Are the two promoters mu- 
tually exclusive or can they be used simultaneously, and do the 
cells have the ability to switch promoters? The detection of 
transcripts specific for the two promoters, by RT-PCR analysis 
(Fig. 4), may suggest that the activity of the two promoters are 
independent rather than exclusive. Transfection of HOS cells 
with a vector over-expressing the transcripts initiated from the 
internal promoter do not exhibit a specific modulation of the 
activity of the distal promoter (data not shown), suggesting that 
indeed the two promoters are independent. 
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Fig. 4. Transcriptional activity of the internal promoter from the cloned 
intron in HOS cells. (A) mRNA was reverse transcribed from the 
primer GAL764. Two rounds of PCR were subsequently performed 
using the 3’ primer MN-38 upstream of GAL764 and with the 5’ primer 
GALi located in the intron sequence. Alternatively, PCR was initi- 
ated with the 5’ primer GAL04, S-GTCCGCAGCCAGCCAACGAG- 
3’, located from nt - 26 to - 7 in the 5’ part of the untranslated mRNA 
produced by the distal promoter. The numbers indicate the expected 
size of the amplified cDNA in bp. Exons (Ex.) and introns (Int.) are not 
drawn to scale. (B) PCR products were analyzed by gel electrophoresis. 
In lane 1, an expected 432 bp fragment is detected after PCR initiated 
with the primers GAL04 and MN-38 In lane 2 are products obtained 
after PCR initiated with the primers GALi and MN-38. In lanes 3 
and 4 are samples amplified under the same conditions as in lanes 1 and 
2 except that the reverse transcription step was omitted. The size marker 
is a 100 bp DNA ladder. 
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The expression of the gene is modulated upon replicative 
competence of cells [17], and is constitutively high in tumour 
cells, particularly in advanced stages of colorectal cancer [ 141. 
This may suggest that the galectin-3 gene is controled by tran- 
scription factors altered during tumorigenesis. Because the ~53 
tumour-suppressor gene encodes a transcription factor which 
is frequently damaged in this type of cancer [32] and because 
the second galectin-3 intron contains a ~53 binding site consen- 
sus sequence, we looked for a putative modulation of the pro- 
moter activity of the second galectin-3 intron by wild-type and 
mutated ~53. Co-transfection of a plasmid encoding wild-type 
~53 produces a drastic decrease in promoter activity. This effect 
is specific of wild-type ~53 and is not detected with a plasmid 
containing a point mutation in the ~53 cDNA. This result 
demonstrates that p53 controls the activity of the internal pro- 
moter of galectin-3 gene as it does for others genes involved in 
the ongoing cell proliferation [33]. Experiments are in progress 
to determine if the distal promoter may be controled by the p53 
status of the cells. 
The determination of the transcription initiation site and the 
cloning of mRNA initiated from the internal promoter from the 
second intron of the galectin-3 gene in several human cells are 
under current investigation in order to define precisely the 
structure and the putative coding sequence of this mRNA. The 
data will be expected to give some insight on elements required 
to understand the appropriate regulation of the gene during the 
normal cell cycle as well as in case of pathological disorders. 
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